Home > Healthcare > Medical Devices > Therapeutic Devices > Trauma Fixation Devices Market

Trauma Fixation Devices Market Analysis

  • Report ID: GMI3745
  • Published Date: Dec 2022
  • Report Format: PDF

Trauma Fixation Devices Market Analysis

Trauma fixation devices market from internal fixator segment is expected to surpass USD 6.5 billion through 2032. The patient preference for internal fixators is rising, owing to their better procedural outcomes. They allow rapid patient recovery, shorter hospital stays, and reduce the incidence of nonunion and malunion of the broken bones. In addition, internal fixation implants are usually made from titanium and stainless steel, which are known to be strong and durable. They are compatible with the body and rarely cause an allergic reaction.
 

Trauma Fixation Devices Market Share By Material

The titanium segment held more than 36.5% of the trauma fixation devices market share in 2022. The increasing segmental growth is owing to the various biomechanical applications associated with titanium, as it is widely used as hard tissue replacements in artificial bone, joints, and implants. Titanium implants are presently gaining importance due to their excellent biocompatibility. Furthermore, characteristics of titanium such as elasticity and corrosion resistance of lower modulus will further augment the market statistics.
 

The trauma fixation devices market share from orthopedic centers is expected to witness more than 4.5% CAGR through 2032. Growing number of knee surgeries and hip replacements in orthopedic centers is expected to positively influence the business outlook. Several orthopedic surgical procedures, such as, joint pain, trauma & sports injuries, osteoarthritis, rheumatoid arthritis, and conditions of the upper & lower extremities are treated at orthopedic centers. Additionally, these centers provide state-of-the-art facilities to address the injury, thus increasing patient preference.
 

Trauma Fixation Devices Market Size By Region

Europe trauma fixation devices market is expected to surpass USD 2.4 billion by 2032. Growing geriatric population and rising prevalence of degenerative bone diseases such as arthritis and osteoporosis will boost market expansion in the region. Osteoarthritis, which is considered as one of the most common types of arthritis as per the CDC, affects more than 40 million people across the continent. The disease is also the fastest growing cause of disability across the globe. With rising life expectancy, and increasing levels of obesity across Europe, the degenerative bone disease burden is likely to rise, thereby channelling the demand for trauma fixation devices. U.S. trauma fixation devices industry is likely to exhibit over 2.5% CAGR from 2023-2032.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for trauma fixation devices was valued at more than USD 8 billion in 2022 and is expected to showcase a 4% CAGR through 2032, owing to the increasing prevalence of degenerative bone diseases.

The internal fixator segment is expected to surpass USD 6.5 billion through 2032, as these devices reduce the incidence of nonunion and malunion of the broken bones.

European market for trauma fixation devices is expected to surpass USD 2.4 billion by end of 2032, driven by the rising prevalence of bone diseases such as osteoarthritis and osteoporosis in the region.

Some prominent companies operating in the market include B Braun Melsungen AG, Acumed LLC, Bioretec LTD, Depuy Synthes (Johnson & Johnson), CONMED Corporation, Integra LifeSciences, Stryker Corporation, Smith & Nephew, and Zimmer Biomet Holdings Inc, among others.

Trauma Fixation Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 9
  • Tables & Figures: 599
  • Countries covered: 27
  • Pages: 295
 Download Free Sample